John Inge Johnsen
Principal Researcher | Docent
E-mail: john.inge.johnsen@ki.se
Visiting address: Widerströmska huset, hiss 1, plan 8 Tomtebodavägen 18A, 17177 Stockholm
Postal address: K6 Kvinnors och barns hälsa, K6 Barnonkologi och Barnkirurgi Kogner/Johnsen, 171 77 Stockholm
About me
- Dr. John Inge Johnsen received his PhD diploma at University of Tromsö,
Norway under the supervision of Professor Terje Traavik in 1994. His thesis
focused on the characterization of regulatory genetic elements in
polyomaviruses and the effects these regulatory regions have on host/virus
interaction.
After finishing his PhD, Dr. Johnsen went on to pursue his main scientific
interest; cancer biology, oncogenes and tumor suppressor genes and 1995 he
joined Professor Eric Stanbridge´s research group at University of
California, Irvine where he studied the effects of p53 and genes regulated by
p53 on cancer development.
After spending two years at the University of Tromsö as an assistant
professor/lecturer Dr. Johnsen joined professor Per Kogner´s research group
at ̽»¨¾«Ñ¡ as a postdoctoral fellow where he together with Dr.
Kogner built up the childhood neural tumor research consortium.
Dr. Johnsen became Associate professor at Karolinska Instituet in 2010.
1984-1990 Msc, University of Tromsö, Norway
1991-1994 PhD, University of Tromsö, Norway
1995-1997 Postdoc, Dr.Stanbridge´s lab, University of California, Irvine,
USA
1997-1998 Postdoc, Dept. of Pediatrics, University of Tromsö Norway
2001-2003 Postdoc, Childhood Cancer Research Unit, Karolinska Istitutet
Research
- The main focus of our research group is to search for new treatment options
that lead to better survival, less treatment-related complications and better
quality of life for children with medulloblastoma and neuroblastoma. This is
done by applying different Omic techniques to characterize the molecular
landscape of malignant and corresponding non-cancerous cells within the tumor
microenvironment and to use a translational approach applying preclinical in
vivo models to characterize the anti-tumorigenic effects of drugs and
compounds targeting specific biological aberrations in cancer cells or
populations of cells located within the tumor microenvironment.
Articles
- Article: CANCER LETTERS. 2025;625:217769
- Article: CANCER RESEARCH. 2025;85(6):1015-1034
- Article: EMBO JOURNAL. 2024;43(24):6310-6335
- Article: CANCER LETTERS. 2024;605:217261
- Article: NEURO-ONCOLOGY. 2024;27(3):779-794
- Journal article: CANCER RESEARCH. 2024;84(17):b060
- Article: MOLECULAR CANCER. 2024;23(1):180
- Article: NUCLEIC ACIDS RESEARCH. 2024;52(5):2648-2671
- Article: CANCERS. 2024;16(4):812
- Article: JCI INSIGHT. 2024;9(6):e173337
- Article: GENOME MEDICINE. 2024;16(1):1
- Journal article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172
- Article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172
- Article: CANCERS. 2023;15(18):4599
- Journal article: NEURO-ONCOLOGY. 2023;25(Suppl 1):i62MDB-04. SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS DISTINCT GENOMIC LANDSCAPES, CELL TRAJECTORIES, AND TUMOUR-MICROENVIRONMENT INTERACTIONS IN FOUR SUBTYPES OF MEDULLOBLASTOMA
- Article: BRITISH JOURNAL OF CANCER. 2022;127(11):2060-2071
- Article: JCI INSIGHT. 2022;7(17):e153836
- Article: CELL REPORTS MEDICINE. 2022;3(6):100657
- Journal article: CANCER RESEARCH. 2022;82(12_Supplement):1677
- Journal article: CANCER RESEARCH. 2022;82(12_Supplement):6215
- Article: LIFE SCIENCES. 2022;295:120394
- Article: CANCER RESEARCH COMMUNICATIONS. 2022;2(3):182-201
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(7):3702
- Article: NATURE COMMUNICATIONS. 2022;13(1):1537
- Article: BMC GENOMICS. 2022;23(1):149
- Article: NEURO-ONCOLOGY ADVANCES. 2022;4(1):vdac028
- Article: JCO PRECISION ONCOLOGY. 2022;6:e2100271
- Article: CANCER DISCOVERY. 2021;11(12):3090-3105
- Article: CANCERS. 2021;13(23):6042
- Article: CANCERS. 2021;13(21):5493
- Article: CELL DEATH & DISEASE. 2021;12(10):914
- Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2021;169:102285
- Article: CANCER RESEARCH. 2021;81(6):1457-1471
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(33):20127-20138
- Article: FASEB JOURNAL. 2020;34(8):11101-11114
- Article: FRONTIERS IN ONCOLOGY. 2020;10:598872
- Article: CANCERS. 2019;12(1):E73-73
- Article: ONCOGENE. 2019;38(15):2800-2813
- Article: CANCERS. 2019;11(2):E202-202
- Article: CANCER LETTERS. 2019;442:341-350
- Article: EBIOMEDICINE. 2018;32:84-92
- Article: PHARMACOLOGICAL RESEARCH. 2018;131:164-176
- Article: ONCOTARGET. 2017;8(56):95135-95151
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(32):E6603-E6612
- Journal article: CANCER RESEARCH. 2017;77:687
- Journal article: CANCER RESEARCH. 2017;77:1945
- Article: SCIENTIFIC REPORTS. 2017;7:46366
- Article: CLINICAL CANCER RESEARCH. 2016;22(15):3849-3859
- Article: CELL REPORTS. 2016;16(4):979-993
- Article: BMC CANCER. 2016;16:490
- Journal article: CANCER RESEARCH. 2016;76:761
- Journal article: CANCER RESEARCH. 2016;76:2454
- Journal article: CANCER RESEARCH. 2016;76:2465
- Journal article: NEURO-ONCOLOGY. 2016;18(suppl_3):iii116
- Journal article: NEURO-ONCOLOGY. 2016;18(Suppl 3):iii116MB-83OMEGA-3 FATTY ACIDS DHA AND EPA SUPPRESS ONCOGENIC PGE2 IN MEDULLOBLASTOMA
- Article: BMC CANCER. 2016;16:259
- Article: MOLECULAR & CELLULAR ONCOLOGY. 2016;3(2):e1131356
- Article: DEVELOPMENTAL CELL. 2016;36(2):164-178
- Article: ONCOIMMUNOLOGY. 2016;5(12):e1232222
- Article: NATURE COMMUNICATIONS. 2015;6:8904
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(26):8070-8075
- Article: JOURNAL OF NEURO-ONCOLOGY. 2015;123(1):1-13
- Journal article: LINDBERGIA. 2015;38(1):30-38
- Article: BMC CANCER. 2014;14:600
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2014;450(4):1600-1605
- Article: PLOS ONE. 2014;9(4):e95628
- Article: CANCER DISCOVERY. 2014;4(4):434-451
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(3):djt459
- Journal article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2014;2(Suppl 3):p203
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(10):2351-2361
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;43(3):831-838
- Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2751
- Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2746
- Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(7):1516-1524
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(4):1239-1248
- Article: BMC MEDICAL GENETICS. 2012;13:83
- Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1807-1815
- Article: PLOS ONE. 2012;7(12):e51297
- Article: PLOS ONE. 2012;7(1):e29331
- Article: ONCOTARGET. 2011;2(12):1329-1338
- Article: INTERNATIONAL JOURNAL OF CANCER. 2011;129(12):2958-2965
- Article: CANCER LETTERS. 2011;310(2):222-231
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2011;121(10):4043-4055
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;411(1):208-212
- Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(7):1703-1711
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;38(3):843-849
- Article: CELL CYCLE. 2010;9(13):2548-2554
- Journal article: CANCER RESEARCH. 2010;70(8_Supplement):4354
- Article: FASEB JOURNAL. 2010;24(3):906-915
- Journal article: ECANCERMEDICALSCIENCE. 2010;4:156
- Article: CANCER RESEARCH. 2010;70(1):266-276
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(44):18757-18762
- Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(5):1227-1234
- Article: FASEB JOURNAL. 2008;22(10):3525-3536
- Article: NEURO-ONCOLOGY. 2008;10(5):661-674
- Article: ONCOGENE. 2008;27(20):2910-2922
- Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(9):2409-2417
- Article: CLINICAL CANCER RESEARCH. 2007;13(3):1036-1044
- Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):493-500
- Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2584-2593
- Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(6):1849-1857
- Article: CANCER RESEARCH. 2004;64(20):7210-7215
- Article: JOURNAL OF MEDICAL VIROLOGY. 2003;70(1):14-19
- Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(4):418-424
- Article: ANTICANCER RESEARCH. 2001;21(6A):3733-3738
- Article: INTERNATIONAL JOURNAL OF CANCER. 2000;88(5):685-691
- Article: CANCER RESEARCH. 1999;59(5):1160-1163
- Article: VIRUS RESEARCH. 1997;52(1):61-71
- Article: NUCLEIC ACIDS RESEARCH. 1996;24(11):2158-2165
- Article: JOURNAL OF GENERAL VIROLOGY. 1995;76:1571-1581
- Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1994;173(2):149-156
- Show more
Employments
- Principal Researcher, Department of Women's and Children's Health, ̽»¨¾«Ñ¡, 2022-
Degrees and Education
- Docent, ̽»¨¾«Ñ¡, 2010